# Extension 3: Third Temporary Rule — DEA telemedicine controlled-substance prescribing flexibility -- extension history For Extension 3: Third Temporary Rule, published is 11/19/2024; federal register citation is 89 FR 91253; document number is 2024-27018; effective period as stated is This rule is effective January 1, 2025, through December 31, 2025; flexibility extended through is December 31, 2025, verified against its source on 2026-08-31. - **Temporary rule:** Extension 3: Third Temporary Rule _(our reading, not quoted from the source)_ - **Published:** 11/19/2024 _(verified: appears in the quote below)_ - **Federal Register citation:** 89 FR 91253 _(verified: appears in the quote below)_ - **Document number:** 2024-27018 _(verified: appears in the quote below)_ - **Effective period as stated:** This rule is effective January 1, 2025, through December 31, 2025. _(verified: appears in its own passage below)_ - **Flexibility extended through:** December 31, 2025 _(verified: appears in its own passage below)_ - **Expiry date this rule replaced:** December 31, 2024 _(verified: appears in its own passage below)_ ## What the source says > A Rule by the Drug Enforcement Administration and the Health and Human Services Department on 11/19/2024 Published Document: 2024-27018 (89 FR 91253) ## Where each value comes from This source states these in separate places, so each value is shown with the passage that states it. ### Effective period as stated > DATES: This rule is effective January 1, 2025, through December 31, 2025. ### Flexibility extended through > The Drug Enforcement Administration (DEA) in concert with the Department of Health and Human Services (HHS) is issuing a third extension of telemedicine flexibilities for the prescribing of controlled medications, through December 31, 2025. ### Expiry date this rule replaced > Paragraph (a) is amended to state that the authorization granted in the amended paragraph (c) expires at the end of December 31, 2025, instead of December 31, 2024. ## Source - https://www.federalregister.gov/d/2024-27018 Last verified: 2026-08-31. Review by: 2026-10-30. Part of [DEA telemedicine controlled-substance prescribing flexibility -- extension history](https://referencesource.org/dea-telemedicine-prescribing-flexibility-extensions/).